Puchany Austin James, Hilmi Ibtesam
Department of Anesthesiology & Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, United States.
School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, United States.
World J Crit Care Med. 2025 Jun 9;14(2):101777. doi: 10.5492/wjccm.v14.i2.101777.
Post-reperfusion syndrome (PRS) in liver transplant recipients remains one of the most dreaded complications in liver transplant surgery. PRS can impact the short-term and long-term patient and graft outcomes. The definition of PRS has evolved over the years, from changes in arterial blood pressures and heart and/or decreases in the systemic vascular resistance and cardiac output to including the fibrinolysis and grading the severity of PRS. However, all that did not reflect on the management of PRS or its impact on the outcomes. In recent years, new scientific techniques and new technology have been in the pipeline to better understand, manage and maybe prevent PRS. These new methods and techniques are still in the infancy, and they have to be proven not in prevention and management of PRS but their effects in the patient and graft outcomes. In this article, we will review the long history of PRS, its definition, etiology, management and most importantly the new advances in science and technology to prevent and properly manage PRS.
肝移植受者的再灌注综合征(PRS)仍然是肝移植手术中最可怕的并发症之一。PRS会影响患者和移植物的短期及长期预后。多年来,PRS的定义不断演变,从动脉血压和心率的变化以及/或全身血管阻力和心输出量的降低,到包括纤维蛋白溶解以及对PRS严重程度进行分级。然而,所有这些都没有反映在PRS的管理或其对预后的影响上。近年来,新的科学技术不断涌现,以便更好地理解、管理甚至预防PRS。这些新方法和技术仍处于起步阶段,它们不仅要在预防和管理PRS方面得到验证,还要在对患者和移植物预后的影响方面得到验证。在本文中,我们将回顾PRS的悠久历史、其定义、病因、管理,最重要的是预防和妥善管理PRS的科学技术新进展。